Reducing HCV in Corrections: Part 1, Surveillance, Screening, Advocacy, and Linkage to Care

Join us for this live, 45-minute, CME/CE/CPE-certified Webinar to find out how you can contribute to the goals of eliminating HCV infection among persons who are incarcerated. The presentation will focus on the importance of understanding the HCV epidemic in your setting, best practices and recommendations for HCV screening in corrections, engaging stakeholders to support HCV services in correctional settings, general considerations for HCV treatment capacity, and models of linkage to care upon re-entry into the community.


Welcome and Overview

Epidemiology of HCV in prisons

National recommendations for HCV screening in jails and prisons

Estimating the feasibility of HCV treatment in jails

Models of linkage to HCV care upon community re-entry

Question and Answer Session


Date / Time
Event Details


Matthew Akiyama, MD

Assistant Professor of Medicine
Divisions of General Internal Medicine & Infectious Diseases
Department of Medicine
Albert Einstein College of Medicine & Montefiore Medical Center
Bronx, New York

Program Overview
The primary purpose of this program is to increase awareness of HCV elimination goals and provide clinicians with practical strategies for meeting these goals within their practice settings. The program focuses on 3 principal at-risk populations that are critical to national HCV elimination goals: people who inject drugs, people who are incarcerated, and men who have sex with men.

Goal Statement
The goal of this activity is to improve participants’ competence in implementing strategies to screen, diagnose, and cure diverse populations of individuals infected with HCV in the United States.

Target Audience 
This program is intended for physicians, registered nurses, pharmacists, and other healthcare providers involved in the screening, diagnosis, and treatment of patients infected with or at elevated risk of HCV.

Learning Objectives

  • Describe the burden of HCV among incarcerated populations
  • Apply current guideline recommendations for universal opt-out HCV testing in jails and prisons
  • Assess data from studies evaluating strategies to improve linkage to HCV care upon community re-entry


Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine, American Society of Addiction Medicine, HealthHCV, and International Network for Hepatitis in Substance Users. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Credit Designation
The Postgraduate Institute for Medicine designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Credit Designation
The maximum number of hours awarded for this Continuing Nursing Education activity is 0.7 contact hours.

Pharmacist Continuing Education

Credit Designation
Postgraduate Institute for Medicine designates this continuing education activity for 0.75 contact hours (0.075 CEUs) of the Accreditation Council for Pharmacy Education.

(Universal Activity Number - JA4008162-9999-19-918-L01-P)

Type of Activity: Knowledge

Pharmacists have up to 30 days to complete the evaluation and claim credit for participation so that information can be submitted to CPE Monitor as required.

Disclosure of Conflicts of Interest 
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. The existence or absence of COI for everyone in a position to control content will be disclosed to participants prior to the start of each activity.